annual FCF:
-$184.46M-$27.73M(-17.70%)Summary
- As of today (September 10, 2025), XENE annual free cash flow is -$184.46 million, with the most recent change of -$27.73 million (-17.70%) on December 31, 2024.
- During the last 3 years, XENE annual FCF has fallen by -$112.91 million (-157.80%).
- XENE annual FCF is now -509.49% below its all-time high of $45.05 million, reached on December 31, 2012.
Performance
XENE Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$66.69M-$5.00M(-8.10%)Summary
- As of today (September 10, 2025), XENE quarterly free cash flow is -$66.69 million, with the most recent change of -$5.00 million (-8.10%) on June 1, 2025.
- Over the past year, XENE quarterly FCF has dropped by -$34.59 million (-107.72%).
- XENE quarterly FCF is now -445.58% below its all-time high of $19.30 million, reached on December 31, 2019.
Performance
XENE quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$232.08M-$34.59M(-17.51%)Summary
- As of today (September 10, 2025), XENE TTM free cash flow is -$232.08 million, with the most recent change of -$34.59 million (-17.51%) on June 1, 2025.
- Over the past year, XENE TTM FCF has dropped by -$76.25 million (-48.93%).
- XENE TTM FCF is now -9496.48% below its all-time high of $2.47 million, reached on September 30, 2014.
Performance
XENE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
XENE Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | -107.7% | -48.9% |
| 3 y3 years | -157.8% | -286.2% | -224.9% |
| 5 y5 years | -2998.2% | -517.8% | -1746.5% |
XENE Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -157.8% | at low | -286.2% | at low | -224.9% | at low |
| 5 y | 5-year | -2998.2% | at low | -517.8% | at low | -1746.5% | at low |
| alltime | all time | -509.5% | at low | -445.6% | at low | -9496.5% | at low |
XENE Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$66.69M(+8.1%) | -$232.08M(+17.5%) |
| Mar 2025 | - | -$61.70M(+18.8%) | -$197.50M(+8.4%) |
| Dec 2024 | -$184.46M(+17.7%) | -$51.91M(+0.3%) | -$182.18M(+11.1%) |
| Sep 2024 | - | -$51.78M(+61.3%) | -$163.96M(+5.2%) |
| Jun 2024 | - | -$32.11M(-30.8%) | -$155.83M(-2.2%) |
| Mar 2024 | - | -$46.38M(+37.6%) | -$159.34M(+6.5%) |
| Dec 2023 | -$156.73M(+50.8%) | -$33.69M(-22.8%) | -$149.58M(+1.5%) |
| Sep 2023 | - | -$43.66M(+22.6%) | -$147.39M(+10.4%) |
| Jun 2023 | - | -$35.61M(-2.8%) | -$133.48M(+15.9%) |
| Mar 2023 | - | -$36.62M(+16.2%) | -$115.14M(+18.5%) |
| Dec 2022 | -$103.92M(+45.2%) | -$31.51M(+5.9%) | -$97.16M(+12.0%) |
| Sep 2022 | - | -$29.75M(+72.3%) | -$86.71M(+21.4%) |
| Jun 2022 | - | -$17.27M(-7.4%) | -$71.43M(+4.0%) |
| Mar 2022 | - | -$18.64M(-11.5%) | -$68.69M(-3.5%) |
| Dec 2021 | -$71.55M(+41.0%) | -$21.06M(+45.6%) | -$71.16M(+9.4%) |
| Sep 2021 | - | -$14.46M(-0.5%) | -$65.04M(+2.6%) |
| Jun 2021 | - | -$14.53M(-31.2%) | -$63.38M(+6.3%) |
| Mar 2021 | - | -$21.11M(+41.4%) | -$59.65M(+14.2%) |
| Dec 2020 | -$50.76M(+752.6%) | -$14.93M(+16.6%) | -$52.25M(+190.0%) |
| Sep 2020 | - | -$12.81M(+18.6%) | -$18.02M(+43.4%) |
| Jun 2020 | - | -$10.80M(-21.3%) | -$12.57M(+18.4%) |
| Mar 2020 | - | -$13.71M(-171.1%) | -$10.61M(+79.8%) |
| Dec 2019 | -$5.95M | $19.30M(-362.3%) | -$5.90M(-81.8%) |
| Sep 2019 | - | -$7.36M(-16.8%) | -$32.39M(-15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$8.84M(-1.8%) | -$38.49M(+9.4%) |
| Mar 2019 | - | -$9.00M(+25.2%) | -$35.18M(+1.7%) |
| Dec 2018 | -$35.23M(+21.3%) | -$7.19M(-46.6%) | -$34.58M(+2.0%) |
| Sep 2018 | - | -$13.46M(+143.2%) | -$33.91M(+12.3%) |
| Jun 2018 | - | -$5.53M(-34.1%) | -$30.19M(-4.0%) |
| Mar 2018 | - | -$8.40M(+28.8%) | -$31.45M(+6.1%) |
| Dec 2017 | -$29.04M(+46.3%) | -$6.52M(-33.1%) | -$29.65M(+8.1%) |
| Sep 2017 | - | -$9.74M(+43.3%) | -$27.43M(+23.7%) |
| Jun 2017 | - | -$6.80M(+3.0%) | -$22.18M(+4.2%) |
| Mar 2017 | - | -$6.60M(+53.5%) | -$21.28M(+8.0%) |
| Dec 2016 | -$19.85M(+6.4%) | -$4.30M(-4.3%) | -$19.71M(-4.4%) |
| Sep 2016 | - | -$4.49M(-23.8%) | -$20.61M(+0.1%) |
| Jun 2016 | - | -$5.89M(+17.2%) | -$20.59M(+19.3%) |
| Mar 2016 | - | -$5.03M(-3.4%) | -$17.27M(-3.4%) |
| Dec 2015 | -$18.65M(+1377.0%) | -$5.21M(+16.5%) | -$17.87M(+9.2%) |
| Sep 2015 | - | -$4.47M(+74.0%) | -$16.36M(+179.1%) |
| Jun 2015 | - | -$2.57M(-54.4%) | -$5.86M(+5.9%) |
| Mar 2015 | - | -$5.63M(+52.3%) | -$5.54M(+350.8%) |
| Dec 2014 | -$1.26M(-63.7%) | -$3.70M(-161.3%) | -$1.23M(-149.7%) |
| Sep 2014 | - | $6.03M(-369.1%) | $2.47M(-169.3%) |
| Jun 2014 | - | -$2.24M(+69.6%) | -$3.56M(+169.6%) |
| Mar 2014 | - | -$1.32M | -$1.32M |
| Dec 2013 | -$3.48M(-107.7%) | - | - |
| Dec 2012 | $45.05M(-422.2%) | - | - |
| Dec 2011 | -$13.98M | - | - |
FAQ
- What is Xenon Pharmaceuticals Inc. annual free cash flow?
- What is the all time high annual FCF for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. annual FCF year-on-year change?
- What is Xenon Pharmaceuticals Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. quarterly FCF year-on-year change?
- What is Xenon Pharmaceuticals Inc. TTM free cash flow?
- What is the all time high TTM FCF for Xenon Pharmaceuticals Inc.?
- What is Xenon Pharmaceuticals Inc. TTM FCF year-on-year change?
What is Xenon Pharmaceuticals Inc. annual free cash flow?
The current annual FCF of XENE is -$184.46M
What is the all time high annual FCF for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high annual free cash flow is $45.05M
What is Xenon Pharmaceuticals Inc. annual FCF year-on-year change?
Over the past year, XENE annual free cash flow has changed by -$27.73M (-17.70%)
What is Xenon Pharmaceuticals Inc. quarterly free cash flow?
The current quarterly FCF of XENE is -$66.69M
What is the all time high quarterly FCF for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high quarterly free cash flow is $19.30M
What is Xenon Pharmaceuticals Inc. quarterly FCF year-on-year change?
Over the past year, XENE quarterly free cash flow has changed by -$34.59M (-107.72%)
What is Xenon Pharmaceuticals Inc. TTM free cash flow?
The current TTM FCF of XENE is -$232.08M
What is the all time high TTM FCF for Xenon Pharmaceuticals Inc.?
Xenon Pharmaceuticals Inc. all-time high TTM free cash flow is $2.47M
What is Xenon Pharmaceuticals Inc. TTM FCF year-on-year change?
Over the past year, XENE TTM free cash flow has changed by -$76.25M (-48.93%)